ArticleBMC nephrology2025
Concurrent IgG4-related membranous nephropathy and proliferative diabetic kidney disease: a diagnostic dilemma and therapeutic strategy in long-standing diabetes.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIgG4-related kidney disease (IgG4-RKD) overlapping with diabetic nephropathy (DND) poses diagnostic challenges in terms of histopathological mimicry. This report highlights the first case of concurrent IgG4-related membranous nephropathy (IgG4-MN) and proliferative diabetic kidney disease (DKD) in a patient with diabetes, emphasizing the use of multidisciplinary diagnostic approaches. A 74-year-old male with a 24-year history of diabetes presented with nephrotic syndrome (proteinuria: 6.9 g/24 h), hypoalbuminemia (26.6 g/L), and lymphadenopathy. The patient's serum IgG4 levels were markedly elevated (2774.7 mg/L). Renal biopsy revealed IgG4-dominant subepithelial deposits (PLA2R-negative) with diabetic glomerulosclerosis, whereas lymph node histopathology confirmed the diagnosis of IgG4-related disease (IgG4-RD). Despite the absence of classic IgG4 + tubulointerstitial nephritis (TIN), integrative serological (hypergammaglobulinemia, IgE elevation), radiological (lymphadenopathy), and histological evidence confirmed the diagnosis of IgG4-MN. Low-dose prednisone and mycophenolate mofetil achieved partial remission (50% proteinuria reduction) without compromising glycemic control.
conclusionThis case highlights the diagnostic complexity of dual renal pathologies in individuals with diabetes and underscores the necessity of multidisciplinary evaluation to differentiate IgG4-MN from DND or primary membranous nephropathy. Early recognition of IgG4-RKD in patients with diabetes and disproportionate proteinuria or systemic inflammation is critical to guide targeted immunosuppression while mitigating metabolic risk. The favorable outcome in this case emphasizes the efficacy of tailored, low-intensity regimens in comorbid populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.